-+ 0.00%
-+ 0.00%
-+ 0.00%

ClearPoint Neuro Lowers FY2026 Sales Guidance from $54.000M-$60.000M to $52.000M-$56.000M

Benzinga·03/17/2026 20:15:15
Listen to the news
ClearPoint Neuro (NASDAQ:CLPT) lowers FY2026 sales outlook from $54.000 million-$60.000 million to $52.000 million-$56.000 million.